TOPO-TB

Projektinformationen

TOPO-TB

ID Finanzhilfevereinbarung: 698260

DOI 10.3030/698260

Abgeschlossenes Projekt

EK-Unterschriftsdatum 29 September 2015

Startdatum 1 Oktober 2015

Enddatum 31 März 2016

Finanziert unter

• SOCIETAL CHALLENGES - Health, demographic change and well-being

Gesamtkosten € 71 429,00

EU-Beitrag € 50 000,00

Koordiniert durch

ZYMONOSTICS APS
Denmark

Ziel

Tuberculosis (TB) remains a major global health problem with 9 million new TB cases and 1.5 million TB deaths in 2013.
Given that with a wide health care access to diagnosis, most deaths are preventable, TB mortality is still unacceptably high.
With TOPO-TB the aim is to develop the first rapid diagnostic kit based on detection of the activity of an essential enzyme of
the bacteria. A high degree of simplicity and low cost, in combination with mycobacteria detection in non-sputum samples,
will enable TOPO-TB to achieve high impact on Tuberculosis control and elimination. Importantly, the low resource
adaptable format meets the requirements of highly competitive TB test, complementing state-of-the-art methods for detection
at the point of care patient level.

Wissenschaftliches Gebiet

• medical and health sciences › health sciences › infectious diseases › malaria
• medical and health sciences › basic medicine › immunology
• medical and health sciences › health sciences › infectious diseases › RNA viruses › HIV
• medical and health sciences › clinical medicine › pneumology › tuberculosis
• natural sciences › biological sciences › biochemistry › biomolecules › proteins › enzymes

Programm/Programme

• H2020-EU.3.1. - SOCIETAL CHALLENGES - Health, demographic change and well-being Main Programme
• H2020-EU.3.1.3. - Treating and managing disease

Thema/Themen

• PHC-12-2015-1 - Clinical research for the validation of biomarkers and/or diagnostic medical devices

Aufforderung zur Vorschlagseinreichung

H2020-SMEInst-2014-2015

Andere Projekte für diesen Aufruf anzeigen

Unterauftrag

H2020-SMEINST-1-2015

Finanzierungsplan

SME-1 - SME instrument phase 1

Koordinator

ZYMONOSTICS APS

• Netto-EU-Beitrag: € 50 000,00
• Adresse: ABOGADE 15 ; 8200 AARHUS N ; Dänemark
• KMU Die Organisation definierte sich zum Zeitpunkt der Unterzeichnung der Finanzhilfevereinbarung selbst als KMU (Kleine und mittlere Unternehmen). Ja:
  Region
  Danmark › Midtjylland › Østjylland
• Region: Danmark › Midtjylland › Østjylland
• Aktivitätstyp: Private for-profit entities (excluding Higher or Secondary Education Establishments)
• Gesamtkosten: € 71 429,00